Search Results

Management will host a conference call on Wednesday August 7, 2019 at 4:30pm Eastern Time to review financial Conference Call / Webcast Information: The live webcast of the conference call can be accessed online at http (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most Research & Business Development Toll-free: 1-844-689-3939 Email: info@anavex.com Investors & Media:

Management will host a conference call on Thursday, May 7th, 2020 at 4:30pm Eastern Time to review financial Conference Call / Webcast Information: The live webcast of the conference call can be accessed online at http (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most Research & Business Development Toll-free: 1-844-689-3939 Email: info@anavex.com Investors & Media:

Management will host a conference call on Thursday, August 6th, 2020 at 11:00 am Eastern Time to review Conference Call / Webcast Information: The live webcast of the conference call can be accessed online at https (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most Research & Business Development Toll-free: 1-844-689-3939 Email: info@anavex.com Investors & Media: Email

Management will host a conference call on Monday December 16, 2019 at 4:30pm Eastern Time to review financial Conference Call / Webcast Information: The live webcast of the conference call can be accessed online at http (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most Research & Business Development Toll-free: 1-844-689-3939 Email: info@anavex.com Investors & Media: Email

(OTCQX: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of novel drug About AD/PD 2015 Attracting international medical and scientific professionals from around the world, projected in any of such statements due to various factors, including the risks set forth in the Company’s most Research & Business Development Toll-free: 1-844-689-3939 Email: info@anavex.com Shareholder & Media

Management will host a conference call on Wednesday, February 7, 2018 at 4:30pm Eastern Time to review Conference Call / Webcast Information The conference call will be available through a live webcast at http (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most Research & Business Development Toll-free: 1-844-689-3939 Email: info@anavex.com Investors & Media: Clayton

Management will host a conference call on Wednesday May 8, 2019 at 4:30pm Eastern Time to review financial Conference Call / Webcast Information: The live webcast of the conference call can be accessed online at http (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most Research & Business Development Toll-free: 1-844-689-3939 Email: info@anavex.com Investors & Media:

Management will host a conference call on Thursday, February 6th, 2020 at 4:30pm Eastern Time to review Conference Call / Webcast Information: The live webcast of the conference call can be accessed online at http (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most Research & Business Development Toll-free: 1-844-689-3939 Email: info@anavex.com Investors & Media:

The study, led by Christian Behl et. al . of the University Medical Center at Johannes Gutenberg University (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most

To access Anavex’s newsroom visit https://www.anavex.com/newsroom. About Anavex Life Sciences Corp. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of novel therapeutics projected in any of such statements due to various factors, including the risks set forth in the Company’s most

To register for the conference, please visit: https://hcwevents.com/annualconference/. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of novel therapeutics projected in any of such statements due to various factors, including the risks set forth in the Company’s most

Additional webcast will be available on the Company's website at https://www.anavex.com/presentations-posters (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated projected in any of such statements due to various factors, including the risks set forth in the Company’s most